Molecular insight into thiopurine resistance: transcriptomic signature in lymphoblastoid cell lines

BACKGROUND: There has been considerable progress in the management of acute lymphoblastic leukemia (ALL) but further improvement is needed to increase long-term survival. The thiopurine agent 6-mercaptopurine (6-MP) used for ALL maintenance therapy has a key influence on clinical outcomes and relaps...

Descripción completa

Detalles Bibliográficos
Autores principales: Chouchana, Laurent, Fernández-Ramos, Ana Aurora, Dumont, Florent, Marchetti, Catherine, Ceballos-Picot, Irène, Beaune, Philippe, Gurwitz, David, Loriot, Marie-Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443628/
https://www.ncbi.nlm.nih.gov/pubmed/26015807
http://dx.doi.org/10.1186/s13073-015-0150-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443628/
https://www.ncbi.nlm.nih.gov/pubmed/26015807
http://dx.doi.org/10.1186/s13073-015-0150-6

Ejemplares similares